header
Image from OpenLibrary

Study of the influence of erythropoietin treatment on hemoglobin A1c levels in diabetic patients with chronic renal failure on hemodialysis / Mahmoud Mohammed Abdelkayiom Mahmoud Elalfy ; Supervised Inas Shaltout , Yasmin Taha Elshiwy , Mohammed Momtaz Mohammed

By: Contributor(s): Material type: TextTextLanguage: English Publication details: Cairo : Mahmoud Mohammed Abdelkayiom Mahmoud Elalfy , 2012Description: 123 P. : charts ; 25cmOther title:
  • دراسة تأثير العلاج بعقار الاريثروبويتين على مستوى الـ ليموجلوبين السكرى بالدم فى مرضى السكر ممن يعانون من فشل مزمن بوظائف الكلى و يعالجون بالاستصفاء الدموى المنتظم [Added title page title]
Subject(s): Available additional physical forms:
  • Issued also as CD
Dissertation note: Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine Summary: Moitoring of glyemic control is the cornerstone of management for insulin-dependent diabetes mellitus, HbA1C levels in hemodialysis patients can be influenced by starting or stopping EPO treatment, and HbA1C levels can decrease or increase according to the increase or decrease of hematocrite caused by changing the EPO dosage, respectively
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
Holdings
Item type Current library Home library Call number Copy number Status Date due Barcode
Thesis Thesis قاعة الرسائل الجامعية - الدور الاول المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2012.Ma.S (Browse shelf(Opens below)) Not for loan 01010110058782000
CD - Rom CD - Rom مخـــزن الرســائل الجـــامعية - البدروم المكتبة المركزبة الجديدة - جامعة القاهرة Cai01.11.18.M.Sc.2012.Ma.S (Browse shelf(Opens below)) 58782.CD Not for loan 01020110058782000

Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine

Moitoring of glyemic control is the cornerstone of management for insulin-dependent diabetes mellitus, HbA1C levels in hemodialysis patients can be influenced by starting or stopping EPO treatment, and HbA1C levels can decrease or increase according to the increase or decrease of hematocrite caused by changing the EPO dosage, respectively

Issued also as CD

There are no comments on this title.

to post a comment.